111 related articles for article (PubMed ID: 12624539)
1. In vivo activation of the interleukin-6 receptor/gp130 signaling pathway in pituitary corticotropes of lipopolysaccharide-treated rats.
Gautron L; Lafon P; Tramu G; Layé S
Neuroendocrinology; 2003 Jan; 77(1):32-43. PubMed ID: 12624539
[TBL] [Abstract][Full Text] [Related]
2. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
[TBL] [Abstract][Full Text] [Related]
3. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
4. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
[TBL] [Abstract][Full Text] [Related]
6. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
Abbud RA; Kelleher R; Melmed S
Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure.
Kamohara Y; Sugiyama N; Mizuguchi T; Inderbitzin D; Lilja H; Middleton Y; Neuman T; Demetriou AA; Rozga J
Biochem Biophys Res Commun; 2000 Jun; 273(1):129-35. PubMed ID: 10873574
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
[TBL] [Abstract][Full Text] [Related]
10. Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3).
Magrangeas F; Boisteau O; Denis S; Jacques Y; Minvielle S
Biochem J; 2001 Jan; 353(Pt 2):223-30. PubMed ID: 11139384
[TBL] [Abstract][Full Text] [Related]
11. Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges.
Lebel E; Vallières L; Rivest S
Endocrinology; 2000 Oct; 141(10):3749-63. PubMed ID: 11014231
[TBL] [Abstract][Full Text] [Related]
12. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
[TBL] [Abstract][Full Text] [Related]
13. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance.
Zolk O; Ng LL; O'Brien RJ; Weyand M; Eschenhagen T
Circulation; 2002 Sep; 106(12):1442-6. PubMed ID: 12234945
[TBL] [Abstract][Full Text] [Related]
14. Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines.
Li QL; Jansen E; Friedman TC
Mol Cell Endocrinol; 1999 Dec; 158(1-2):143-52. PubMed ID: 10630414
[TBL] [Abstract][Full Text] [Related]
15. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
Bousquet C; Zatelli MC; Melmed S
J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
[TBL] [Abstract][Full Text] [Related]
16. Expression of functional ciliary neurotrophic factor receptors in immortalized gonadotrophin-releasing hormone-secreting neurones.
Dozio E; Watanobe H; Ruscica M; Maggi R; Motta M; Magni P
J Neuroendocrinol; 2005 May; 17(5):286-91. PubMed ID: 15869563
[TBL] [Abstract][Full Text] [Related]
17. SOCS3 regulates the plasticity of gp130 signaling.
Lang R; Pauleau AL; Parganas E; Takahashi Y; Mages J; Ihle JN; Rutschman R; Murray PJ
Nat Immunol; 2003 Jun; 4(6):546-50. PubMed ID: 12754506
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta.
Vallières L; Rivest S
J Neurochem; 1997 Oct; 69(4):1668-83. PubMed ID: 9326296
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions.
Mazzarella G; MacDonald TT; Salvati VM; Mulligan P; Pasquale L; Stefanile R; Lionetti P; Auricchio S; Pallone F; Troncone R; Monteleone G
Am J Pathol; 2003 Jun; 162(6):1845-55. PubMed ID: 12759242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
